Glow Lifetech Achieves 146% Revenue Growth and Debt-Free Status with Positive Cash Flow
Glow Lifetech delivered 146% year-over-year revenue growth in FY2025 while maintaining a 66% gross margin and generating two consecutive quarters of positive operating cash flow. The company achieved debt-free status by eliminating $368,509 in long-term debt and narrowed its Q4 EBITDA loss to $17,238.
1. FY 2025 Financial Results
Glow Lifetech reported a record 146% year-over-year revenue increase in FY2025, sustaining a 66% gross margin and generating two consecutive quarters of positive cash flow, reflecting improved operating efficiency and strong top-line momentum.
2. Q4 2025 Operational Metrics
Net revenue rose 53% to $508,225, gross profit increased 44% to $323,350, operating cash flow reached $105,866 and the EBITDA loss narrowed by 85% to $17,238, nearing breakeven in the quarter.
3. Balance Sheet Strength and Brand Expansion
The company eliminated all $368,509 in long-term debt to achieve debt-free status, expanded MOD™ and .decimal™ brands into Saskatchewan, Manitoba and New Brunswick, and launched its product portfolio on the national medical cannabis platform.
4. 2026 Strategic Outlook
Glow Lifetech forecasts continued revenue and EBITDA growth in 2026, driven by expanded distribution across Canada, disciplined capital management and its MyCell Technology® platform’s scalability toward sustainable profitability.